Improving outcomes in high-risk prostate cancer with radiotherapy.

Polkinghorn, William R; Zelefsky, Michael J

Polkinghorn, William R; Zelefsky, Michael J.

Afiliación

Polkinghorn WR; Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, United States.
Zelefsky MJ; Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, United States.

Rep Pract Oncol Radiother ; 18(6): 333-7, 2013 Nov 11.

Article en En | MEDLINE | ID: mdl-24416574

Palabras clave

Androgen receptor; Androgen-deprivation therapy; Anti-androgen agents; External beam radiation therapy; High-risk prostate cancer

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Clinical_trials / Etiology_studies / Risk_factors_studies Idioma: En Revista: Rep Pract Oncol Radiother Año: 2013 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google